vimarsana.com
Home
Live Updates
Upadacitinib Superior in Efficacy to Dupilumab for Atopic De
Upadacitinib Superior in Efficacy to Dupilumab for Atopic De
Upadacitinib Superior in Efficacy to Dupilumab for Atopic Dermatitis in Head-to-Head Study
New phase 3b/4 trial data compared both drugs efficacy and safety profiles for eczema patients, looking at adults and adolescents.
Related Keywords
Jonathan Silverberg ,
Health Sciences ,
George Washington University School Of Medicine ,
Gw Medical Faculty Associates Jonathan Silverberg ,
Drug Administration ,
Faculty Associates ,
George Washington University School ,
Eczema Area ,
Severity Index ,
Worst Pruritus Numerical Rating Scale ,